Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma

Hajime Tamura,Makoto Suzuki,Yasumitsu Moriya,Hidehisa Hoshino,Tatsuro Okamoto,Shigetoshi Yoshida,Ichiro Yoshino

Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma

2011

Hajime Tamura
Makoto Suzuki
Yasumitsu Moriya
Hidehisa Hoshino
Tatsuro Okamoto
Shigetoshi Yoshida
Ichiro Yoshino

Background N-methyl-D-aspartate receptors (NMDAR) act as tumor suppressors of digestive malignancies. The expression and genetic methylation patterns of NMDAR2B in non-small cell lung cancer (NSCLC) are unknown.

Keywords:

Cancer research
Small-cell carcinoma
Pathology
Methylation
DNA methylation
Cell
Lung cancer
Small Cell Lung Carcinoma
Receptor
Cell culture
Biology
Suppressor
Surgical oncology
Azacitidine
Carcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations